Sitagliptin Ameliorates Renal Tubular Injury in Diabetic Kidney Disease via STAT3-Dependent Mitochondrial Homeostasis Through SDF-1α/CXCR4 Pathway

Q Zhang, L He, F Liu, J Guan, Y Dong, Y Fei, J Wen… - 2019 - papers.ssrn.com
Background: Mitochondrial abnormalities play critical roles in diabetic tubular injury
progression. Dipeptidyl peptidase-4 (DPP4) inhibitors are widely used antihyperglycaemic …
被引用次数：34 相关文章

Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway.

Q Zhang, L He, Y Dong, Y Fei, J Wen, X Li… - … : Official Publication of …, 2020 - europepmc.org
Mitochondrial abnormalities play critical roles in diabetic tubular injury progression.
Dipeptidyl peptidase-4 (DPP4) inhibitors are widely used antihyperglycemic agents that …

Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway

Q Zhang, L He, Y Dong, Y Fei, J Wen… - … publication of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Mitochondrial abnormalities play critical roles in diabetic tubular injury progression.
Dipeptidyl peptidase-4 (DPP4) inhibitors are widely used antihyperglycemic agents that …

Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3‐dependent mitochondrial homeostasis through SDF‐1α/CXCR4 pathway

Q Zhang, L He, Y Dong, Y Fei, J Wen, X Li… - The FASEB …, 2020 - Wiley Online Library
Mitochondrial abnormalities play critical roles in diabetic tubular injury progression.
Dipeptidyl peptidase‐4 (DPP4) inhibitors are widely used antihyperglycemic agents that …